Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02177877
Other study ID # SM-29027
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 2014
Est. completion date December 2015

Study information

Verified date July 2021
Source Stanford University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study will assess whether a movement detecting wristwatch can accurately detect seizures and seizure characteristics and record them into an online epilepsy diary. The patients may manually record a description into the online epilepsy diary of the symptoms they experienced before, during or after the seizure.


Description:

Typically, health care providers receive inaccurate patient self- reports. This pilot trial will document the feasibility of accurately recording and logging seizures into a cloud-based diary, under circumstances of controlled video-EEG monitoring to serve as a comparison "gold standard." More explicitly, we are testing the efficacy of the wristwatch in capturing movement parameters correlated with seizure activity and whether these parameters can be accurately uploaded into an online epilepsy diary. In the future, biosensor data could be valuable to more precisely obtain seizure data for clinical decision making as well as use in clinical trials.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date December 2015
Est. primary completion date December 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: -Adults over the age of 18 with known epileptic convulsive seizures already being admitted to the EMU for continuous video EEG. Exclusion Criteria: - Patients with only non-convulsive events or only psychogenic non-epileptic seizures. - Patients who are unable to provide consent. - Patients who have developmental delay.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Stanford Hospital and Clinics Stanford California

Sponsors (2)

Lead Sponsor Collaborator
Stanford University SmartMonitor

Country where clinical trial is conducted

United States, 

References & Publications (1)

Velez M, Fisher RS, Bartlett V, Le S. Tracking generalized tonic-clonic seizures with a wrist accelerometer linked to an online database. Seizure. 2016 Jul;39:13-18. doi: 10.1016/j.seizure.2016.04.009. Epub 2016 Apr 29. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Recording accuracy of convulsive seizure events by the watch and watch-diary interface compared to vEEG Will measure the date and time, duration and shake intensity of convulsive seizure events by the watch and watch-diary interface compared to vEEG up to 7 days
Other Feasibility of use of device Will survey whether the device was easy, neutral, difficult to use up to 7 days
Other Recording accuracy of partial seizures Will compare partial seizure events detected by vEEG vs. watch-diary vs. patient log vs. caregiver log up to 7 days
Primary Capture rate of convulsive seizure events by the watch and watch-diary interface compared to video electroencephalography (vEEG) up to 7 days
Secondary Capture rate of non-seizure events by the watch and watch-diary interface compared to vEEG up to 7 days
Secondary Frequency of movements of the watch diary interface vs vEEG up to 7 days
Secondary Amplitude of movements of the watch diary interface vs vEEG up to 7 days
Secondary Seizure semiology captured by the watch vs vEEG. up to 7 days.
Secondary Specificity of audio recordings of the watch vs vEEG Will record audio through the watch and vEEG to assess the specificity of this parameter for epileptic vs nonepileptic seizures up to 7 days
See also
  Status Clinical Trial Phase
Completed NCT04595513 - Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants Phase 1/Phase 2
Completed NCT02909387 - Adapting Project UPLIFT for Blacks in Georgia N/A
Completed NCT05552924 - Self Acupressure on Fatigue and Sleep Quality in Epilepsy Patients N/A
Terminated NCT01668654 - Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS Phase 3
Not yet recruiting NCT05068323 - Impact of Interictal Epileptiform Activity on Some Cognitive Domains in Newly Diagnosed Epileptic Patients N/A
Completed NCT03994718 - Creative Arts II Study N/A
Recruiting NCT04076449 - Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy
Completed NCT00782249 - Trial Comparing Different Stimulation Paradigms in Patients Treated With Vagus Nerve Stimulation for Refractory Epilepsy N/A
Completed NCT03683381 - App-based Intervention for Treating Insomnia Among Patients With Epilepsy N/A
Recruiting NCT05101161 - Neurofeedback Using Implanted Deep Brain Stimulation Electrodes N/A
Active, not recruiting NCT06034353 - Impact of Pharmacist-led Cognitive Behavioral Intervention on Adherence and Quality of Life of Epileptic Patients N/A
Recruiting NCT05769933 - Bridging Gaps in the Neuroimaging Puzzle: New Ways to Image Brain Anatomy and Function in Health and Disease Using Electroencephalography and 7 Tesla Magnetic Resonance Imaging
Not yet recruiting NCT06408428 - Glioma Intraoperative MicroElectroCorticoGraphy N/A
Not yet recruiting NCT05559060 - Comorbidities of Epilepsy(Cognitive and Psychiatric Dysfunction)
Completed NCT02952456 - Phenomenological Approach of Epilepsy in Patients With Epilepsy
Completed NCT02977208 - Impact of Polymorphisms of OCT2 and OCTN1 on the Kinetic Disposition of Gabapentin in Patients Undergoing Chronic Use Phase 4
Completed NCT02646631 - Behavioral and Educational Tools to Improve Epilepsy Care N/A
Recruiting NCT02539134 - TAK-935 Multiple Rising Dose Study in Healthy Participants Phase 1
Terminated NCT02757547 - Transcranial Magnetic Stimulation for Epilepsy N/A
Completed NCT02491073 - Study to Evaluate Serum Free Thyroxine (FT4) and Free Triiodothyronine (FT3) Measurements for Subjects Treated With Eslicarbazeine Acetate (ESL) N/A